- Home
- MYO vs CMRX Comparison
MYO vs CMRX Comparison
Compare MYO & CMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MYO
- CMRX
- Stock Information
- Founded
- MYO 2004
- CMRX 2000
- Country
- MYO United States
- CMRX United States
- Employees
- MYO N/A
- CMRX N/A
- Industry
- MYO Industrial Specialties
- CMRX Biotechnology: Pharmaceutical Preparations
- Sector
- MYO Health Care
- CMRX Health Care
- Exchange
- MYO Nasdaq
- CMRX Nasdaq
- Market Cap
- MYO 121.5M
- CMRX 80.7M
- IPO Year
- MYO 2017
- CMRX 2013
- Fundamental
- Price
- MYO $3.81
- CMRX $0.87
- Analyst Decision
- MYO Strong Buy
- CMRX Strong Buy
- Analyst Count
- MYO 4
- CMRX 1
- Target Price
- MYO $7.63
- CMRX $11.00
- AVG Volume (30 Days)
- MYO 107.4K
- CMRX 137.2K
- Earning Date
- MYO 11-05-2024
- CMRX 10-31-2024
- Dividend Yield
- MYO N/A
- CMRX N/A
- EPS Growth
- MYO N/A
- CMRX N/A
- EPS
- MYO N/A
- CMRX N/A
- Revenue
- MYO $21,111,062.00
- CMRX $144,000.00
- Revenue This Year
- MYO $53.19
- CMRX $3,040.12
- Revenue Next Year
- MYO $39.01
- CMRX N/A
- P/E Ratio
- MYO N/A
- CMRX N/A
- Revenue Growth
- MYO 21.22
- CMRX N/A
- 52 Week Low
- MYO $1.06
- CMRX $0.75
- 52 Week High
- MYO $5.64
- CMRX $1.30
- Technical
- Relative Strength Index (RSI)
- MYO 46.02
- CMRX 47.54
- Support Level
- MYO $3.74
- CMRX $0.80
- Resistance Level
- MYO $4.05
- CMRX $0.91
- Average True Range (ATR)
- MYO 0.18
- CMRX 0.05
- MACD
- MYO 0.00
- CMRX -0.00
- Stochastic Oscillator
- MYO 22.12
- CMRX 48.20
About MYO Myomo Inc.
Myomo Inc is a wearable medical robotics company that develops, designs, and produces myoelectric orthotics for people with neuromuscular disorders. The MyoPro myoelectric upper limb orthosis product is registered with the Food and Drug Administration as a Class II medical device. The Company provides the devices to patients and bills their insurance companies directly, sometimes utilizing the clinical services of orthotics and prosthetics providers for which a fee is paid. The Company sells the product to orthotics and prosthetics providers around the world and the Veterans Health Administration (VA).
About CMRX Chimerix Inc.
Chimerix Inc. is a biopharmaceutical company based in the United States that engages in the research, development, and commercialization of medicines. Its portfolio includes treatment for acute myeloid leukemia (or AML) and antiviral treatment for smallpox. The company generates revenue through revenue related to non-refundable upfront fees, royalties and milestone payments earned under license agreements, also by royalty revenue related to sales of TEMBEXA made by Emergent after the Asset Sale. The company operates only in one business segment namely pharmaceuticals.